Reviews Multiple Electrolytes Inj


No reviews yet.

Plasma-Lyte 148 Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/5/2008




Plasma-Lyte 148 Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/5/2008




Plasma-Lyte 148 Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/5/2008




Plasma-Lyte 148 Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/5/2008




Plasma-Lyte 148 Drug Description
PLASMA-LYTE 148 and 5% Dextrose Injection
(multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose
Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte
replenishment and caloric supply in a single dose container for intravenous
administration. Each 100 mL contains 5 g Dextrose Hydrous, USP*, 526 mg Sodium
Chloride, USP (NaCl); 502 mg Sodium Gluconate (C6H11NaO7);
368 mg Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O),
37 mg Potassium Chloride, USP (KCl); and 30 mg Magnesium Chloride, USP (MgCl2•6H2O).
It contains no antimicrobial agents. The pH is 5.0 (4.0 to 6.5). The pH is adjusted
with hydrochloric acid.







D-Glucopyranose monohydrate
PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) administered intravenously has value as a source of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate and 23 mEq gluconate. The osmolarity is 547 mOsmol/L (calc). Normal physiologic osmolarity range is approximately 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions (≥600 mOsmol/L) may cause vein damage. The caloric content is 190 kcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological
evaluations, which have shown the container passes Class VI U.S. Pharmacopeia
(USP) testing for plastic containers. These tests confirm the biological safety
of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/5/2008





Other reviews about Multiple Electrolytes Inj on wordpress

One afternoon he came in sobb
  by hddcfpjcpd
Its out, and thats an end of it. That was when e wanted for to wash isself in the Fort Ditch, Ortheris explained. Looking across the valley, […]


For there might not have bee
  by wpualjandnmtc
He still rode the board now and then, when the surf was high. It tasted like a combination of paper and library paste. Judds paper on the Volcanoes […]


He became a leader of th
  by xqisfyaffprnee
His tulips are up ever so much higher than ours, and I asked him how he managed to coax them along so early. Ive been in this institution […]


no, I am sure you are
  by lumkievuyjc
They were standing at a craps table, watching the action, and Eddie was deciding whether or not to put a bet down and go with the shooter. The […]


899=0
  by salavats
uninstall vlc plugin mac osx baja bug a arm conversion thank you to sponsors letter conference lauren bowden barrel racing animated icons hilton lax promotion code adp paycheck excel weed eater manual 115254226 rev3 gta san […]


uninstall vlc plugin mac osx baja bug a arm conve …
  by salavats
uninstall vlc plugin mac osx baja bug a arm conversion thank you to sponsors letter conference lauren bowden barrel racing animated icons hilton lax promotion code adp paycheck excel weed eater manual 115254226 rev3 gta san […]


uninstall vlc plugin mac osx baja bug a arm conve …
  by gelopy
uninstall vlc plugin mac osx baja bug a arm conversion thank you to sponsors letter conference lauren bowden barrel racing animated icons hilton lax promotion code adp paycheck excel weed eater manual 115254226 rev3 gta san […]


uninstall vlc plugin mac osx baja bug a arm conve …
  by gelopy
uninstall vlc plugin mac osx baja bug a arm conversion thank you to sponsors letter conference lauren bowden barrel racing animated icons hilton lax promotion code adp paycheck excel weed eater manual 115254226 rev3 gta san […]


EHR Data (HealthFlow background info)
  by user
  This description applied to RetroGuide (retrospective component of the HealthFlow system, but it is still valid to the overall HealthFlow system (which indludes retrospective mode (RetroGuide) […]



Other reviews about Multiple Electrolytes Inj on web:

1. Orv Hetil. 2001 Jul 8;142(27):1449-53. [Plasma electrolytes in multiple myeloma] [Article in Hungarian] Miseta A, Kellermayer M, Liszt F, Ludány A, Magyarlaki T, Sipos K ... [Plasma electrolytes in multiple myeloma]


Learn about the prescription medication Plasma-Lyte 148 (Multiple Electrolytes Inj), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Plasma-Lyte 148 (Multiple Electrolytes Inj) Drug Information: Uses ...


Find out all about Injury from an external force, including the most common causes, symptoms and treatments from leading medical experts. Multiple Electrolytes And Dextrose Inj Dosage - a comprehensive ...


Multiple Myeloma; Myelodysplastic Syndrome; Neuroblastoma; Non-Hodgkin's Lymphoma ... Electrolytes are chemicals in the body that regulate important physiological functions. Electrolyte Imbalance | Cancer News


Learn about the prescription medication Plasma-Lyte 56 and Dextrose (Multiple Electrolytes and Dextrose Injection in Viaflex Plastic Container), drug uses, dosage, side effects ... Plasma-Lyte 56 and Dextrose (Multiple Electrolytes and Dextrose ...


Rapid death of multiple tumor cells can cause electrolyte imbalance, including high levels of potassium and phosphorus and decreased levels of calcium. It also results in elevated ... Cancer Therapy-Side Effects of Therapy-Electrolyte Imbalances ...


fireflyhealth.com - Virtual support groups, social networking and information for medical conditions, journals, blogs and discussion forums - connect with other people sharing your ... MULTIPLE ELECTROLYTE ADDITIVE INJ,CONC - FireflyHealth


Polyethylene has the highest affinity for the bacteria- martindale - the extra pharmacopoeia 29th edition page 1603. whereas polypropylene is internationally accepted usfda most ... Container, Multiple Electrolytes, Dextrose In Peritonidal Dialysis ...


fireflyhealth.com - Virtual support groups, social networking and information for medical conditions, journals, blogs and discussion forums - connect with other people sharing your ... HIGH ACETATE MULTIPLE ELECTROLYTE ADDITIVE INJ - FireflyHealth


Normosol-R (Multiple Electrolytes Injection Type 1, USP) is supplied in 500 and 1000 mL single-dose flexible plastic containers (List No. 7967). NORMOSOL®-RMULTIPLE ELECTROLYTES INJECTION TYPE 1, USP ...





Featured Reviews

Reviews Insulin Lispro

Humalog Mix 50-50 Drug Description HUMALOG® Mix50/50™ (50% insulin lispro protamine suspension AND 50% insulin lispro injection (rDNA ORIGIN) 100 UNITS PER ML (U-100) DRUG DESCRIPTION What are the possible side effects...
Read More  |  Review This
Reviews Aminosyn HBC 7% Sulfite Free

Aminosyn HBC 7% Sulfite Free Drug Description AMINOSYN®-HBC 7% Sulfite-Free AN AMINO ACID INJECTION HIGH BRANCHED CHAIN Flexible Plastic Container DRUG DESCRIPTION Aminosyn®-HBC 7%, Sulfite-Free, (an amino acid injection...
Read More  |  Review This
Reviews Loteprednol Etabonate and Tobramycin

Zylet Drug Description Zylet™ (loteprednol etabonate and tobramycin) Ophthalmic Suspension, 0.5%/0.3% Sterile DRUG DESCRIPTION What are the possible side effects of loteprednol and tobramycin ophthalmic (Zylet)? If you experience...
Read More  |  Review This
Reviews Albuterol Sulfate Inhalation Solution

Ventolin Solution Drug Description DRUG DESCRIPTION What are the possible side effects of albuterol (Proventil, Proventil Repetabs, Ventolin, Volmax)? Stop taking albuterol and seek emergency medical attention if you experience...
Read More  |  Review This
Reviews Vascor

Vascor Drug Description VASCOR (bepridil hydrochloride) DRUG DESCRIPTION What are the possible side effects of bepridil (Vascor)? If you experience any of the following serious side effects, stop taking bepridil and call your doctor...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....